Ribomic Inc. (TYO: 4591)
Japan
· Delayed Price · Currency is JPY
84.00
+1.00 (1.20%)
Sep 27, 2024, 11:05 AM JST
Ribomic Statistics
Total Valuation
Ribomic has a market cap or net worth of JPY 3.18 billion. The enterprise value is 29.27 million.
Market Cap | 3.18B |
Enterprise Value | 29.27M |
Important Dates
The next estimated earnings date is Monday, November 11, 2024.
Earnings Date | Nov 11, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Ribomic has 38.29 million shares outstanding. The number of shares has increased by 9.10% in one year.
Shares Outstanding | 38.29M |
Shares Change (YoY) | +9.10% |
Shares Change (QoQ) | +2.07% |
Owned by Insiders (%) | 3.99% |
Owned by Institutions (%) | 2.38% |
Float | 35.56M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2,978.33 |
PB Ratio | 0.95 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.03 |
EV / Sales | 29.27 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 21.62
Current Ratio | 21.62 |
Quick Ratio | 21.24 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -26.14% and return on invested capital (ROIC) is -17.91%.
Return on Equity (ROE) | -26.14% |
Return on Assets (ROA) | -17.08% |
Return on Capital (ROIC) | -17.91% |
Revenue Per Employee | 41,667 |
Profits Per Employee | -39.33M |
Employee Count | 24 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -38.69% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -38.69% |
50-Day Moving Average | 90.98 |
200-Day Moving Average | 94.50 |
Relative Strength Index (RSI) | 41.09 |
Average Volume (20 Days) | 2,822,115 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Ribomic had revenue of JPY 1.00 million and -944.00 million in losses. Loss per share was -26.31.
Revenue | 1.00M |
Gross Profit | 1.00M |
Operating Income | -1.04B |
Pretax Income | -943.00M |
Net Income | -944.00M |
EBITDA | -1.02B |
EBIT | -1.04B |
Loss Per Share | -26.31 |
Balance Sheet
Cash & Cash Equivalents | 3.15B |
Total Debt | n/a |
Net Cash | 3.15B |
Net Cash Per Share | 82.24 |
Equity (Book Value) | 3.17B |
Book Value Per Share | 87.04 |
Working Capital | 3.13B |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | 100.00% |
Operating Margin | -103,500.00% |
Pretax Margin | -94,300.00% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Ribomic does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -9.10% |
Shareholder Yield | -9.10% |
Earnings Yield | -31.70% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Ribomic has an Altman Z-Score of 15.33.
Altman Z-Score | 15.33 |
Piotroski F-Score | n/a |